11 – 20 of 45
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
The hidden story of heterogeneous B-raf V600E mutation quantitative protein expression in metastatic melanoma—association with clinical outcome and tumor phenotypes
(
- Contribution to journal › Article
- 2017
-
Mark
NF1-mutated melanoma tumors harbor distinct clinical and biological characteristics
(
- Contribution to journal › Article
-
Mark
Correlation of histopathologic characteristics to protein expression and function in malignant melanoma
(
- Contribution to journal › Article
- 2016
-
Mark
High TERT promoter mutation frequency in non-acral cutaneous metastatic melanoma
(
- Contribution to journal › Letter
-
Mark
Germline CDKN2A Mutation Status and Survival in Familial Melanoma Cases
(
- Contribution to journal › Article
-
Mark
Multiregion whole-exome sequencing uncovers the genetic evolution and mutational heterogeneity of early-stage metastatic melanoma
(
- Contribution to journal › Article
- 2015
-
Mark
A protein deep sequencing evaluation of metastatic melanoma tissues.
(
- Contribution to journal › Article
-
Mark
Molecular stratification of metastatic melanoma using gene expression profiling: prediction of survival outcome and benefit from molecular targeted therapy.
(
- Contribution to journal › Article
-
Mark
The clinicopathological and gene expression patterns associated with ulceration of primary melanoma
(
- Contribution to journal › Article
-
Mark
CDKN2a mutation-negative melanoma families have increased risk exclusively for skin cancers but not for other malignancies.
(
- Contribution to journal › Article